Abstract:Liver cancer is one of the most common malignancies. T-cell exhaustion is associated with immunosuppression of tumor and chronic infection. Although immunotherapies that enhance the immune response by targeting programmed cell death-1(PD-1)/programmed cell death ligand 1 (PD-L1) have been applied to malignancies, these treatments have shown limited response rates. This suggested that additional inhibitory receptors (IRs) also contributed to T-cell exhaustion and tumor prognosis. Exhausted T-cells (Tex) in the tumor immune microenvironment (TME) are usually in a dysfunctional state of exhaustion, such as impaired activity and proliferative ability, increased apoptosis rate, and reduced production of effector cytokines. Tex cells participate in the negative regulation of tumor immunity mainly through IRs on the cell surface, changes in cytokines and immunomodulatory cell types, causing tumor immune escape. However, T-cell exhaustion is not irreversible and targeted immune checkpoint inhibitors (ICIs) can effectively reverse the exhaustion of T-cells and restore the anti-tumor immune response. Therefore, the research on the mechanism of T-cell exhaustion in liver cancer, aimed at maintaining or restoring the effector function of Tex cells, might provide a new method for the treatment of liver cancer. In this review, we summarized the basic characteristics of Tex cells (such as IRs and cytokines), discussed the mechanisms associated with T-cell exhaustion, and specifically discussed how these exhaustion characteristics were acquired and shaped by key factors within TME. Then new insights into the molecular mechanism of T-cell exhaustion suggested a potential way to improve the efficacy of cancer immunotherapy, namely to restore the effector function of Tex cells. In addition, we also reviewed the research progress of T-cell exhaustion in recent years and provided suggestions for further research.

Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer

Reinvigorating Exhausted CD8+ Cytotoxic T Lymphocytes in the Tumor Microenvironment and Current Strategies in Cancer Immunotherapy

Advances in T cells-based immunotherapy for non-small cell lung cancer

T cell exhaustion in human cancers

Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy

Molecular insight into T cell exhaustion in hepatocellular carcinoma

T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications

Strategies to reinvigorate exhausted CD8+ T cells in tumor microenvironment

Clinical implications of T cell exhaustion for cancer immunotherapy

Editorial: Immune cell exhaustion: new challenges and opportunities in cancer therapy

Targeting EIF4F complex in non-small cell lung cancer cells.

New insights into T-cell exhaustion in liver cancer: from mechanism to therapy

Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion

T Cell Dysfunction and Exhaustion in Cancer

CD8+ T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy

Non-immune cell components in tumor microenvironment influencing lung cancer Immunotherapy

Fundamentals to therapeutics: Epigenetic modulation of CD8+ T Cell exhaustion in the tumor microenvironment

Advances of Immunotherapy Resistance and Coping Strategies in Non-small Cell Lung Cancer

Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells

Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy

Mechanisms of T cell exhaustion guiding next-generation immunotherapy